Highvista Strategies LLC / CELG
Highvista Strategies LLC’s Celgene Corp Position
Does Highvista Strategies LLC own Celgene Corp (CELG)? Not currently — the last reported position was 36.8K shares worth $4M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q3 2019
Shares
36.8K
% of Portfolio
+2.49%
Quarters Held
3
position exited
Position History CELG
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of CELG.